10-104142324-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_025145.7(CFAP43):āc.4228A>Gā(p.Lys1410Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000558 in 1,613,538 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_025145.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CFAP43 | ENST00000357060.8 | c.4228A>G | p.Lys1410Glu | missense_variant | 33/38 | 1 | NM_025145.7 | ENSP00000349568.3 | ||
CFAP43 | ENST00000434629.5 | c.2221A>G | p.Lys741Glu | missense_variant | 18/23 | 1 | ENSP00000391364.1 | |||
CFAP43 | ENST00000457071.5 | c.772A>G | p.Lys258Glu | missense_variant | 7/12 | 2 | ENSP00000394274.1 | |||
CFAP43 | ENST00000479392.1 | n.-9A>G | upstream_gene_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152182Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000120 AC: 3AN: 250730Hom.: 0 AF XY: 0.0000148 AC XY: 2AN XY: 135536
GnomAD4 exome AF: 0.00000342 AC: 5AN: 1461356Hom.: 0 Cov.: 30 AF XY: 0.00000413 AC XY: 3AN XY: 726954
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152182Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74344
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 19, 2024 | The c.4228A>G (p.K1410E) alteration is located in exon 33 (coding exon 33) of the CFAP43 gene. This alteration results from a A to G substitution at nucleotide position 4228, causing the lysine (K) at amino acid position 1410 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at